Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Total Reportable Segments by Quarter
Total Reportable Segments — Adjusted Operating Gain (Non-GAAP) ($M)
Elevance Health Total Reportable Segments: $1,337M in Q3 2026, down 0.5% from a year earlier.
Latest, Q3 2026
1,337
Period ended Sep 30, 2026
Change on a year earlier
-0.5%
1,344 in Q3 2025
History
16 quarters
Since Q4 2022
Sources
12
Documents cited below
Where the Q3 2026 figure comes from
“|| Reportable segments adjusted operating gain | $ | 1,337 | $ | 1,344 | (0.5) | % | $ | 6,359 | $ | 7,087 | (10.3) | %”
Source: 8-K ER (FY2026Q3, 2026-10-21) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Reportable Segments — Adjusted Operating Gain (Non-GAAP) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 1,337 | -0.5% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 1,818 | -26.9% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 3,204 | -1.6% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 375 | -55.4% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,344 | -45.3% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,488 | -14.2% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 3,255 | +4.1% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 841 | -38.1% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 2,459 | -2.7% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,901 | +8.0% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,126 | +9.4% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,358 | +3.3% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 2,528 | – | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 2,685 | – | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 2,858 | – | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,315 | – | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
Cite this data
StockData. (2026). Elevance Health Total Reportable Segments ($M), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-op-gain-adjusted-total
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.